ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,948Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 117

$1.75M Total Retail Price of All Prescriptions

Rank: 8 out of 117

739 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 739 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

30% of this provider’s 739 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 24,631 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 26.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
HYDROCODONE-ACETAMINOPHEN 1,134 843 S3 1 3
SIMVASTATIN 973 800 2 2
LEVOTHYROXINE SODIUM 958 894 3 1
FUROSEMIDE 929 802 4 4
AMLODIPINE BESYLATE 895 765 5 5
DONEPEZIL HCL 836 776 6 10
LISINOPRIL 810 648 7 6
NOVOLIN R 792 660 10 8 40
METOPROLOL TARTRATE 665 582 9 8
POTASSIUM CHLORIDE 596 509 10 11
MIRTAZAPINE 567 512 11 14
QUETIAPINE FUMARATE 545 465 12 20
WARFARIN SODIUM 541 450 13 13
NAMENDA 508 468 14 7
GABAPENTIN 491 380 15 12
CARVEDILOL 468 364 16 22
CITALOPRAM HBR 459 386 17 18
OMEPRAZOLE 435 372 18 9
LANTUS 379 260 19 25
SERTRALINE HCL 341 285 20 16
TRAZODONE HCL 310 257 21 23
TRAMADOL HCL 289 263 22 19
METFORMIN HCL 285 234 23 15
LIDODERM 276 274 24 62
RISPERIDONE 271 250 25 35
LEVETIRACETAM 236 114 26 46
TAMSULOSIN HCL 235 202 27 31
HYDRALAZINE HCL 227 187 28 50
FAMOTIDINE 223 191 29 49
ZOLPIDEM TARTRATE 222 181 30 24
PANTOPRAZOLE SODIUM 210 206 31 39
ESCITALOPRAM OXALATE 205 186 32 29
FLUTICASONE PROPIONATE 203 166 33 44
TRAVATAN Z 192 181 34 104
SEROQUEL 182 151 35 57
CLOPIDOGREL 176 153 36 30
LACTULOSE 175 144 37 65
HYDROCHLOROTHIAZIDE 174 144 38 28
PROMETHAZINE HCL 171 127 R 39 77
CLONIDINE HCL 170 136 40 52
CALCITONIN-SALMON 164 147 41 181
LEVOFLOXACIN 163 129 42 55
LYRICA 161 118 43 73
ATORVASTATIN CALCIUM 161 153 43 21
LATANOPROST 159 158 45 84
BACLOFEN 154 61 46 74
METOPROLOL SUCCINATE 152 148 47 17
CYMBALTA 151 126 48 27
IPRATROPIUM-ALBUTEROL 145 140 49 59
DIVALPROEX SODIUM 144 133 50 37
RANITIDINE HCL 144 111 50 43
NOVOLIN 70-30 141 88 52 165
LOSARTAN POTASSIUM 141 126 52 32
CARBIDOPA-LEVODOPA 137 123 54 53
ISOSORBIDE MONONITRATE ER 133 126 55 48
PLAVIX 131 107 56 41
KLOR-CON M10 125 114 57 76
AZITHROMYCIN 121 109 58 64
ADVAIR DISKUS 120 108 59 71
ALENDRONATE SODIUM 119 117 60 26
DIGOXIN 117 113 61 45
DIVALPROEX SODIUM ER 115 79 62 83
DIOVAN 114 100 63 38
ALLOPURINOL 113 106 64 66
NITROFURANTOIN MONO-MACRO 113 93 64 100
FLUOXETINE HCL 111 46 66 95
EXELON 108 101 67 34
NYSTATIN 106 81 68 81
ALBUTEROL SULFATE 102 72 69 68
CYCLOBENZAPRINE HCL 98 54 R 70 110
HUMULIN R 98 49 70 109
OXYBUTYNIN CHLORIDE 97 63 72 121
LIDOCAINE HCL 96 89 73 125
IPRATROPIUM BROMIDE 95 73 74 93
CIPROFLOXACIN HCL 92 85 75 56
CEPHALEXIN 90 75 76 123
TRANSDERM-SCOP 90 68 76 217
SPIRONOLACTONE 90 75 76 69
PRAVASTATIN SODIUM 90 72 76 33
CELEBREX 90 75 76 134
PAROXETINE HCL 89 71 81 82
KLOR-CON M20 88 72 82 54
NEXIUM 86 68 83 36
JANTOVEN 85 66 84 120
GLIPIZIDE 84 68 85 51
SANTYL 83 54 86 100
TRIAMCINOLONE ACETONIDE 82 49 87 145
GLUCAGEN 81 77 88 186
SULFAMETHOXAZOLE-TRIMETHOPRIM 80 67 89 79
DORZOLAMIDE-TIMOLOL 80 67 89 220
LABETALOL HCL 80 56 89 234
ROPINIROLE HCL 79 71 92 89
PREDNISONE 78 57 93 47
METOCLOPRAMIDE HCL 78 46 93 91
BRIMONIDINE TARTRATE 74 57 95 167
RENVELA 73 51 96 163
PHENYTOIN SODIUM EXTENDED 71 29 97 96
LEXAPRO 69 58 98 86
ATENOLOL 68 55 99 42
AGGRENOX 66 66 100 153
MEGESTROL ACETATE 65 46 R 101 135
CLONIDINE 64 60 102 136
TRIAMTERENE-HCTZ 63 55 103 94
AMIODARONE HCL 62 50 104 98
NOVOLIN N 61 60 105 172
PHENYTOIN 60 35 106 175
MUPIROCIN 60 48 106 113
PATANOL 56 53 108 112
LIDOCAINE 56 53 108 295
ONDANSETRON HCL 55 51 110 202
CLOBETASOL PROPIONATE 55 54 110 297
NOVOLOG 53 35 112 60
FENTANYL 52 44 S2 113 103
GLYBURIDE 52 28 R 113 108
DETROL LA 52 52 113 146
CEFTRIAXONE 51 38 116 129
TIMOLOL MALEATE 50 50 117 191
TRICOR 50 31 117 119
ISOSORBIDE DINITRATE 50 26 117 166
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 30, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.